Double metastatic cancer with lung and urothelial carcinoma responding to enfortumab vedotin: a case report and review of the literature
Abstract Background For patients with metastatic lung adenocarcinoma, systemic therapy with platinum-based chemotherapy associated with immunotherapy is the standard of care. The treatment decision seems to be more difficult with a second cancer occurrence during the treatment course. Here we report...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-12-01
|
| Seri Bilgileri: | Journal of Medical Case Reports |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s13256-025-05739-5 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|